Physician profile
Tamara E Saunders
NPI 1649590654
$2,836.79
in general payments reported to CMS, 2019-2025
21 companies · $705 in 2025
The $705 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,242 · 2020: $37.81 · 2021: $73.48 · 2022: $214 · 2023: $373 · 2024: $193 · 2025: $705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260 · Travel and Lodging: $10.73.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.74 |
| Travel and Lodging | $10.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $674.25 | 2019 | |
| Stryker Corporation | $472.18 | 2023-2025 | Spy-Phi System, Molli |
| Elucent Medical | $387.47 | 2025 | |
| Allergan, INC. | $379.74 | 2019-2022 | |
| Hologic Sales and Service, LLC | $176.54 | 2025 | Magtrace, Localizer |
| Abbvie INC. | $134.81 | 2023 | Alloderm, Natrelle Saline-Filled Breast Implants |
| Zimmer Biomet Holdings, INC. | $120.61 | 2019 | |
| Acell, INC. | $87.83 | 2019 | |
| Davol INC. | $63.01 | 2019 | |
| Becton, Dickinson and Company | $61.50 | 2022 | |
| Tetraphase Pharmaceuticals, INC. | $46.04 | 2019 | |
| Kerecis Limited | $37.43 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Covidien Lp | $34.45 | 2019 | |
| Molli Surgical (US) INC | $24.06 | 2024 | |
| Shire North American Group INC | $23.99 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $23.52 | 2019 | |
| Merck Sharp & Dohme LLC | $19.37 | 2024 | Bridion |
| Takeda Pharmaceuticals U.S.A., INC. | $19.20 | 2020 | |
| Integra Lifesciences Corporation | $18.61 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $16.52 | 2019 | |
| Boston Scientific Corporation | $15.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Saunders listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.